331 related articles for article (PubMed ID: 38222069)
1. Doxorubicin-induced cardiotoxicity and risk factors.
Belger C; Abrahams C; Imamdin A; Lecour S
Int J Cardiol Heart Vasc; 2024 Feb; 50():101332. PubMed ID: 38222069
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Abrahams C; Woudberg NJ; Lecour S
Lipids Health Dis; 2022 Sep; 21(1):85. PubMed ID: 36050733
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-induced cardiotoxicity: causative factors and possible interventions.
Jones IC; Dass CR
J Pharm Pharmacol; 2022 Nov; 74(12):1677-1688. PubMed ID: 35994421
[TBL] [Abstract][Full Text] [Related]
6. The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity.
Gaytan SL; Lawan A; Chang J; Nurunnabi M; Bajpeyi S; Boyle JB; Han SM; Min K
Front Physiol; 2023; 14():1133423. PubMed ID: 36969584
[TBL] [Abstract][Full Text] [Related]
7. Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
Kalyanaraman B
Redox Biol; 2020 Jan; 29():101394. PubMed ID: 31790851
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis.
Yamaguchi N; Fujii T; Aoi S; Kozuch PS; Hortobagyi GN; Blum RH
Eur J Cancer; 2015 Nov; 51(16):2314-20. PubMed ID: 26343314
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
[TBL] [Abstract][Full Text] [Related]
11. Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity.
Sumneang N; Tanajak P; Oo TT
Molecules; 2023 May; 28(11):. PubMed ID: 37298770
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.
Maayah ZH; Takahara S; Dyck JRB
Arch Toxicol; 2021 Jan; 95(1):1-9. PubMed ID: 32852568
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes.
Cui N; Wu F; Lu WJ; Bai R; Ke B; Liu T; Li L; Lan F; Cui M
J Cell Mol Med; 2019 Jul; 23(7):4627-4639. PubMed ID: 31106979
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity.
Ojha S; Al Taee H; Goyal S; Mahajan UB; Patil CR; Arya DS; Rajesh M
Oxid Med Cell Longev; 2016; 2016():5724973. PubMed ID: 27313831
[TBL] [Abstract][Full Text] [Related]
15. Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α.
Ma T; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
Mol Biol Rep; 2019 Feb; 46(1):105-118. PubMed ID: 30362071
[TBL] [Abstract][Full Text] [Related]
16. EPAC1 inhibition protects the heart from doxorubicin-induced toxicity.
Mazevet M; Belhadef A; Ribeiro M; Dayde D; Llach A; Laudette M; Belleville T; Mateo P; Gressette M; Lefebvre F; Chen J; Bachelot-Loza C; Rucker-Martin C; Lezoualch F; Crozatier B; Benitah JP; Vozenin MC; Fischmeister R; Gomez AM; Lemaire C; Morel E
Elife; 2023 Aug; 12():. PubMed ID: 37551870
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
[TBL] [Abstract][Full Text] [Related]
18. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress injury in doxorubicin-induced cardiotoxicity.
Songbo M; Lang H; Xinyong C; Bin X; Ping Z; Liang S
Toxicol Lett; 2019 Jun; 307():41-48. PubMed ID: 30817977
[TBL] [Abstract][Full Text] [Related]
20. 17β-estradiol protects against doxorubicin-induced cardiotoxicity in male Sprague-Dawley rats by regulating NADPH oxidase and apoptosis genes.
Zhang XJ; Cao XQ; Zhang CS; Zhao Z
Mol Med Rep; 2017 May; 15(5):2695-2702. PubMed ID: 28447737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
